Journal
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Volume 48, Issue 6, Pages 935-937Publisher
MOSBY, INC
DOI: 10.1067/mjd.2003.8
Keywords
-
Categories
Ask authors/readers for more resources
The treatment of vulvar lichen sclerosus is generally considered difficult. Ultrapotent corticosteroids represent the most effective topical treatment, but carry the risk of side effects Such as skin atrophy. We describe a 71-year-old woman with long-standing vulvar lichen sclerosus refractory to conventional treatment. After 6 consecutive weeks of treatment with tacrolimus ointment 0.1% (Protopic) twice daily, signs and symptoms of lichen sclerosus resolved. To Our knowledge, this is the first report of the use of topical tacrolinius, which does not induce skin atrophy, in the treatment of vulvar lichen sclerosus.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available